ALZ-801 Market Size and Forecast ALZ-801 (valiltramiprosate) is positioned within the rapidly evolving Alzheimer’s Disease (AD) therapeutics market, which is projected to reach significant valuations, with the broader AD market expected to…
PTSD Blarcamesine Market: Size, Forecast, Drivers, and Key Trends
PTSD Blarcamesine Market Size and Forecast The market for Blarcamesine in Post-Traumatic Stress Disorder (PTSD) is nascent, currently centered on its potential and ongoing clinical development by Anavex Life Sciences. While Blarcamesine…
OCD Droxidopa Market: Size, Forecast, Drivers, and Key Trends
Droxidopa Market Size and Forecast The global Droxidopa market is expected to demonstrate substantial growth, driven by its established use in treating symptomatic neurogenic orthostatic hypotension (nOH). The market size was estimated…
Schiz Evenamide Market: Size, Forecast, Drivers, and Key Trends
Evenamide Market Size and Forecast The Evenamide market size is currently based on its potential as an add-on therapy for chronic schizophrenia patients who respond poorly to existing second-generation antipsychotics. As Evenamide…
Anx MM-120 Market: Size, Forecast, Drivers, and Key Trends
MM120 Market Size and Forecast (Anxiety Therapeutics) MM120 (LSD D-Tartrate) is an investigational psychoactive substance primarily being developed for Generalized Anxiety Disorder (GAD). As it is currently in Phase 3 clinical trials,…
Dep Exxua Market: Size, Forecast, Drivers, and Key Trends
Exxua Market Size and Forecast EXXUA (gepirone extended-release) is a first-in-class antidepressant recently approved by the FDA for Major Depressive Disorder (MDD). The drug enters the substantial United States prescription MDD market,…
HF Empagliflozin Generics Market: Size, Forecast, Drivers, and Key Trends
HF Empagliflozin Generics Market Size and Forecast The generics market for Empagliflozin (indicated for heart failure, or HF, and diabetes) is currently nascent but holds significant future growth potential. As Empagliflozin is…
AF Milvexian Market: Size, Forecast, Drivers, and Key Trends
AF Milvexian Market Size and Forecast Milvexian is a novel, investigational oral Factor XIa inhibitor being co-developed by Bristol Myers Squibb and Johnson & Johnson. As it is still in Phase 3…
HTN IONIS-AGT Market: Size, Forecast, Drivers, and Key Trends
HTN IONIS-AGT Market Size and Forecast The market for HTN IONIS-AGT (Zilebesiran) is currently nascent but holds immense potential within the multi-billion dollar global hypertension treatment sector. As a novel RNA interference…
Hyperchol VERVE-101 Market: Size, Forecast, Drivers, and Key Trends
VERVE-101 Market Size and Forecast The market potential for VERVE-101 is vast, targeting severe genetic hypercholesterolemia like heterozygous familial hypercholesterolemia (HeFH). As a first-in-class *in vivo* CRISPR base editor designed to permanently…